Podokinesis in endothelial cell migration: Role of nitric oxide

American Journal of Physiology - Cell Physiology

Volumn 274, Issue 1 43-1, 1998, Pages

  Noiri, Eisei ^b   Lee, Eugene ^b   Testa, Jacqueline ^b   Quigley, James ^b   Colflesh, David ^b   Keese, Charles R ^b   Giaever, Ivar ^b   Goligorsky, Michael S ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b NONE

Author keywords

Chorioallantoic membrane; Electrical impedance; Vascular endothelial growth factor; Vectorial locomotion

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL MIGRATION; EPITHELIUM CELL; GROWTH REGULATION; IMPEDANCE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; WOUND HEALING;

ANIMALIA; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0031886882     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1998.274.1.c236     Document Type: Article

References (33)

1. Beauvais, F., L. Michel, and L. Dubertret. Exogenous nitric oxide elicits chemotaxis of neutrophils in vitro. J. Cell. Physiol. 165: 610-614, 1995.
2. Dvorak, H. F., L. Brown, M. Detmar, and A. M. Dvorak. Vascular permeability factor/vascular endothelial growth factor, microvascular permeability, and angiogenesis. Am. J. Pathol. 146: 1029-1039, 1995.
3. Flavahan, N. A. Atheroclerosis or lipoprotein-induced endothelial dysfunction: potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 85: 1927-1938, 1992.
4. Folkman, J. Tumor angiogenesis. Adv. Cancer Res. 43: 175-203, 1985.
5. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1: 27-31, 1995.
6. Giaever, I., and C. R. Keese. Micromotion of mammalian cells measured electrically. Proc. Natl. Acad. Sci. USA 88: 7896-7900, 1991.
7. Gospodarowicz, D., J. Abraham, and J. Schilling. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculostellate cells. Proc. Natl. Acad. Sci. USA 86: 7311-7315, 1989.
8. Ichimori, K., H. Ishida, M. Fukabori, H. Nakazawa, and E. Murakami. Practical nitric oxide measurement employing a nitric oxide-sensitive electrode. Rev. Sci. Instrum. 65: 1-5, 1994.
9. Jenkins, D., I. Charles, L. Thomsen, D. Moss, L. Holmes, S. Baylis, P. Rhodes, K. Westmore, P. Emson, and S. Moncada. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA 92: 4392-4396, 1995.
10. Ku, D., J. Zaleski, S. Liu, and T. A. Brock. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H586-H592, 1993.
11. Kubes, P., M. Suzuki, and D. N. Granger. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88: 4651-4655, 1991.
12. Lefer, A. M., and X. Ma. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler. Thromb. 13: 771-776, 1993.
13. Leibovich, S. J., P. Polverini, T. Fong, L. Harlow, and A. E. Koch. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. USA 91: 4190-4194, 1994.
14. Leung, D. W., G. Cachianes, W. Kuang, D. Goeddel, and N. Ferrara. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
15. Levy, A., N. Levy, S. Wegner, and M. A. Goldberg. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270: 13333-13400, 1995.
16. Liao, J., W. Shin, W. Lee, and S. Clark. Oxidized LDL decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 270: 319-324, 1995.
17. Lo, C.-M., C. R. Keese, and I. Giaever. Monitoring motion of confluent cells in tissue culture. Exp. Cell Res. 204: 102-109, 1993.
18. Marks, D. S., J. Vita, J. Folts, J. Keaney, G. Welch, and J. Loscalzo. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J. Clin. Invest. 96: 2630-2638, 1995.
19. Millauer, B., S. Wiigmann-Voos, H. Schnurch, R. Martinez, N. Moller, W. Risau, and A. Ullrich. High affinity VEGF binding and developmental expresion suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835-846, 1993.
20. Morbidelli, L., C.-H. Chang, J. G. Douglas, H. J. Granger, F. Ledda, and M. Ziehe. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H411-H415, 1996.
21. Mustonen, T., and K. Alitalo. Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell Biol. 129: 895-898, 1995.
22. Noiri, E., Y. Hu, W. F. Bahou, C. Keese, I. Giaever, and M. S. Goligorsky. Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. J. Biol. Chem. 272: 1747-1752, 1997.
23. Noiri, E., T. Peresleni, N. Srivastava, P. Weber, W. F. Bahou, N. Peunova, and M. S. Goligorsky. Nitric oxide is necessary for a switch from stationary to locomoting phenotype in epithelial cells. Am. J. Physiol. 270 (Cell Physiol. 39): C794-C802, 1996.
24. Oliver, T., J. Lee, and K. Jacobson. Forces exerted by locomoting cells. Semin. Cell Biol. 5: 139-147, 1994.
25. O'Reilly, M. S., L. Holmgren, Y. Shing, C. Chen, R. A. Rosenthal, M. Moses, W. S. Lane, Y. Cao, E. H. Sage, and J. Folkman. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328, 1994.
26. Shimonaka, M., and Y. Yamaguchi. Purification and biological characterization of epitaxin, a fibroblast-derived motility factor for epithelial cells. J. Biol. Chem. 269: 14284-14289, 1994.
27. Shweiki, D., A. Itin, D. Soffer, and E. Keshet. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
28. Singer, S. J., and A. Kupfer. The directed migration of eukaryotic cells. Annu. Rev. Cell Biol. 2: 337-365, 1986.
29. Sundqvist, T., T. Forslund, T. Bengtsson, and K. Axelsson. S-nitroso-N-acetylpenicillamine reduces leukocyte adhesion to type I collagen. Inflammation 18: 625-631, 1994.
30. Tsukahara, H., H. Ende, H. I. Magazine, W. F. Bahou, and M. S. Goligorsky. Molecular and functional characterization of the non-isopeptide-selective ET receptor in endothelial cells. Receptor coupling to nitric oxide synthase. J. Biol. Chem. 269: 21778-21785, 1994.
31. Tsukahara, H., D. V. Gordienko, B. Tonschoff, M. C. Gelato, and M. S. Goligorsky. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int. 45: 598-604, 1994.
32. Von der Leyen, H., G. Gibbons, R. Morishita, N. Lewis, L. Zhang, M. Nakajima, Y. Kaneda, J. Cooke, and V. J. Dzau. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. USA 92: 1137-1141, 1995.
33. Ziche, M., L. Morbidelli, E. Masini, S. Amerini, H. Granger, C. Maggi, P. Geppetti, and F. Ledda. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94: 2036-2044, 1994.